• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疾病建模和再生医学的工程化肝脏微组织

Engineering liver microtissues for disease modeling and regenerative medicine.

作者信息

Huang Dantong, Gibeley Sarah B, Xu Cong, Xiao Yang, Celik Ozgenur, Ginsberg Henry N, Leong Kam W

机构信息

Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.

Institute of Human Nutrition, Columbia University Irving Medical Center, New York, NY 10032, USA.

出版信息

Adv Funct Mater. 2020 Oct 28;30(44). doi: 10.1002/adfm.201909553. Epub 2020 Feb 19.

DOI:10.1002/adfm.201909553
PMID:33390875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7774671/
Abstract

The burden of liver diseases is increasing worldwide, accounting for two million deaths annually. In the past decade, tremendous progress has been made in the basic and translational research of liver tissue engineering. Liver microtissues are small, three-dimensional hepatocyte cultures that recapitulate liver physiology and have been used in biomedical research and regenerative medicine. This review summarizes recent advances, challenges, and future directions in liver microtissue research. Cellular engineering approaches are used to sustain primary hepatocytes or produce hepatocytes derived from pluripotent stem cells and other adult tissues. Three-dimensional microtissues are generated by scaffold-free assembly or scaffold-assisted methods such as macroencapsulation, droplet microfluidics, and bioprinting. Optimization of the hepatic microenvironment entails incorporating the appropriate cell composition for enhanced cell-cell interactions and niche-specific signals, and creating scaffolds with desired chemical, mechanical and physical properties. Perfusion-based culture systems such as bioreactors and microfluidic systems are used to achieve efficient exchange of nutrients and soluble factors. Taken together, systematic optimization of liver microtissues is a multidisciplinary effort focused on creating liver cultures and on-chip models with greater structural complexity and physiological relevance for use in liver disease research, therapeutic development, and regenerative medicine.

摘要

肝脏疾病的负担在全球范围内不断增加,每年导致200万人死亡。在过去十年中,肝脏组织工程的基础研究和转化研究取得了巨大进展。肝脏微组织是小型三维肝细胞培养物,可重现肝脏生理功能,已用于生物医学研究和再生医学。本文综述了肝脏微组织研究的最新进展、挑战和未来方向。细胞工程方法用于维持原代肝细胞或产生源自多能干细胞和其他成年组织的肝细胞。三维微组织通过无支架组装或支架辅助方法(如大封装、液滴微流控和生物打印)生成。肝脏微环境的优化需要纳入合适的细胞组成以增强细胞间相互作用和特定微环境信号,并创建具有所需化学、机械和物理特性的支架。基于灌注的培养系统(如生物反应器和微流控系统)用于实现营养物质和可溶性因子的有效交换。总之,肝脏微组织的系统优化是一项多学科努力,专注于创建具有更高结构复杂性和生理相关性的肝脏培养物和芯片模型,用于肝脏疾病研究、治疗开发和再生医学。

相似文献

1
Engineering liver microtissues for disease modeling and regenerative medicine.用于疾病建模和再生医学的工程化肝脏微组织
Adv Funct Mater. 2020 Oct 28;30(44). doi: 10.1002/adfm.201909553. Epub 2020 Feb 19.
2
Engineered microtissues to model the effects of dynamic heterotypic cell signaling on iPSC-derived human hepatocyte maturation.构建工程化微组织以模拟动态异型细胞信号对诱导多能干细胞衍生的人肝细胞成熟的影响。
Acta Biomater. 2025 May 1;197:135-151. doi: 10.1016/j.actbio.2025.03.020. Epub 2025 Mar 13.
3
Biofabrication and bioprinting using cellular aggregates, microtissues and organoids for the engineering of musculoskeletal tissues.使用细胞聚集体、微组织和类器官进行生物制造和生物打印,以工程化肌肉骨骼组织。
Acta Biomater. 2021 May;126:1-14. doi: 10.1016/j.actbio.2021.03.016. Epub 2021 Mar 9.
4
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease.用于非酒精性脂肪性肝病建模的生物工程肝微组织
EXCLI J. 2023 Mar 20;22:367-391. doi: 10.17179/excli2022-5892. eCollection 2023.
5
High-throughput scaffold-free microtissues through 3D printing.通过3D打印实现的高通量无支架微组织
3D Print Med. 2018 Nov 22;4(1):9. doi: 10.1186/s41205-018-0029-4.
6
Availability, Functionality, and Safety as well as Quality Control of Hepatocytes as Seeding Cells in Liver Regenerative Medicine: State of the Art and Challenges.作为肝再生医学中种子细胞的肝细胞的可用性、功能和安全性以及质量控制:现状和挑战。
Curr Stem Cell Res Ther. 2023;18(8):1090-1105. doi: 10.2174/1574888X18666230125113254.
7
A decade of progress in liver regenerative medicine.肝脏再生医学的十年进展。
Biomaterials. 2018 Mar;157:161-176. doi: 10.1016/j.biomaterials.2017.11.027. Epub 2017 Nov 24.
8
High-throughput production of liver parenchymal microtissues and enrichment of organ-specific functions in gelatin methacrylamide microenvironment.在明胶甲基丙烯酰胺微环境中高通量生产肝实质微组织并富集器官特异性功能。
Biotechnol Bioeng. 2022 Mar;119(3):1018-1032. doi: 10.1002/bit.28010. Epub 2022 Jan 7.
9
Multicellular Co-Culture in Three-Dimensional Gelatin Methacryloyl Hydrogels for Liver Tissue Engineering.三维明胶甲基丙烯酰水凝胶中的多细胞共培养用于肝脏组织工程。
Molecules. 2019 May 7;24(9):1762. doi: 10.3390/molecules24091762.
10
Advances in Regenerative Medicine and Biomaterials.再生医学和生物材料的进展。
Methods Mol Biol. 2023;2575:127-152. doi: 10.1007/978-1-0716-2716-7_7.

引用本文的文献

1
Advancing hepatotoxicity assessment: current advances and future directions.推进肝毒性评估:当前进展与未来方向
Toxicol Res. 2025 Apr 24;41(4):303-323. doi: 10.1007/s43188-025-00289-w. eCollection 2025 Jul.
2
Construction of vascularized liver microtissues recapitulates angiocrine-mediated hepatocytes maturation and enhances therapeutic efficacy for acute liver failure.血管化肝微组织的构建概括了血管分泌介导的肝细胞成熟,并增强了对急性肝衰竭的治疗效果。
Bioact Mater. 2025 Apr 29;50:525-539. doi: 10.1016/j.bioactmat.2025.04.030. eCollection 2025 Aug.
3
Recent Advances in the Development and Application of Cell-Loaded Collagen Scaffolds.

本文引用的文献

1
Liver Tissue Engineering: Challenges and Opportunities.肝脏组织工程:挑战与机遇
ACS Biomater Sci Eng. 2019 Sep 9;5(9):4167-4182. doi: 10.1021/acsbiomaterials.9b00745. Epub 2019 Aug 19.
2
Fiber-Reinforced Silk Composite for Enhanced Urokinase Production Using High-Density Perfusion Culture and Bioactive Molecule Supplementation.用于通过高密度灌注培养和生物活性分子补充提高尿激酶产量的纤维增强丝复合材料
ACS Biomater Sci Eng. 2019 Nov 11;5(11):6137-6151. doi: 10.1021/acsbiomaterials.9b01162. Epub 2019 Oct 7.
3
Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues.
负载细胞的胶原蛋白支架的开发与应用的最新进展
Int J Mol Sci. 2025 Apr 24;26(9):4009. doi: 10.3390/ijms26094009.
4
3D bioprinting for bile duct tissue engineering: current status and prospects.用于胆管组织工程的3D生物打印:现状与展望
Front Bioeng Biotechnol. 2025 Apr 14;13:1554226. doi: 10.3389/fbioe.2025.1554226. eCollection 2025.
5
Hydrogel-Based Strategies for Liver Tissue Engineering.基于水凝胶的肝组织工程策略
Chem Bio Eng. 2024 Sep 24;1(11):887-915. doi: 10.1021/cbe.4c00079. eCollection 2024 Dec 26.
6
Scaffold-mediated liver regeneration: A comprehensive exploration of current advances.支架介导的肝脏再生:当前进展的全面探索
J Tissue Eng. 2024 Oct 13;15:20417314241286092. doi: 10.1177/20417314241286092. eCollection 2024 Jan-Dec.
7
Decellularized liver scaffolds for constructing drug-metabolically functional human liver models.用于构建具有药物代谢功能的人肝模型的去细胞肝支架
Bioact Mater. 2024 Sep 23;43:162-180. doi: 10.1016/j.bioactmat.2024.09.029. eCollection 2025 Jan.
8
Framework nucleic Acid-MicroRNA mediated hepatic differentiation and functional hepatic spheroid development for treating acute liver failure.框架核酸-微小RNA介导的肝分化及功能性肝球体发育用于治疗急性肝衰竭
Bioact Mater. 2024 Aug 27;41:611-626. doi: 10.1016/j.bioactmat.2024.08.022. eCollection 2024 Nov.
9
Celery-derived scaffolds with liver lobule-mimicking structures for tissue engineering transplantation.用于组织工程移植的具有肝小叶模拟结构的芹菜衍生支架。
Smart Med. 2022 Dec 16;1(1):e20220002. doi: 10.1002/SMMD.20220002. eCollection 2022 Dec.
10
Recent advances in liver-on-chips: Design, fabrication, and applications.肝脏芯片的最新进展:设计、制造与应用
Smart Med. 2023 Feb 12;2(1):e20220010. doi: 10.1002/SMMD.20220010. eCollection 2023 Feb.
多细胞三维人肝微组织的转录组学、蛋白质组学及长期功能特性分析
Appl In Vitro Toxicol. 2018 Mar 1;4(1):1-12. doi: 10.1089/aivt.2017.0022.
4
Biomaterial-assisted scalable cell production for cell therapy.用于细胞治疗的生物材料辅助可扩展细胞生产
Biomaterials. 2020 Feb;230:119627. doi: 10.1016/j.biomaterials.2019.119627. Epub 2019 Nov 14.
5
Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary.从前肠-中肠交界处模拟人类肝胆胰发生。
Nature. 2019 Oct;574(7776):112-116. doi: 10.1038/s41586-019-1598-0. Epub 2019 Sep 25.
6
Derivation and applications of human hepatocyte-like cells.人肝细胞样细胞的衍生与应用。
World J Stem Cells. 2019 Aug 26;11(8):535-547. doi: 10.4252/wjsc.v11.i8.535.
7
Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model.在一种新型多细胞器官型肝脏模型中,靶向CYP4A可减轻肝脏脂肪变性。
J Biol Eng. 2019 Aug 8;13:69. doi: 10.1186/s13036-019-0198-8. eCollection 2019.
8
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids.TM6SF2 E167K 基因变异可诱导人肝 3D 球体中的脂质生物合成并降低载脂蛋白 B 的分泌。
Sci Rep. 2019 Aug 12;9(1):11585. doi: 10.1038/s41598-019-47737-w.
9
Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells.鉴定原代人肝细胞和 HepG2 细胞来源的分泌蛋白。
Nutrients. 2019 Aug 3;11(8):1795. doi: 10.3390/nu11081795.
10
Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature.生物人工肝支持系统治疗急性肝衰竭:临床和临床前文献的系统评价和荟萃分析。
World J Gastroenterol. 2019 Jul 21;25(27):3634-3648. doi: 10.3748/wjg.v25.i27.3634.